You have no items in your shopping cart.
All Products
Biotinylated Human GUCY2C (C-6His-Avi) [orb2993659]Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 48.6 KDa. Observed: 65-110 KDa, reducing conditions
100 μg, 20 μg- Biotinylated Human BAFF (N-Avi-Fc) [orb2993660]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.8 KDa. Observed: 50-60 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human TREM-2 (C-Avi-6His) [orb2993661]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.1 KDa. Observed: 30-40 KDa, reducing conditions
100 μg, 20 μg - Recombinant Human TREM2 (C-Fc) [orb2993662]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.4 KDa. Observed: 55-65 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Cynomolgus TREM2 (C-6His) [orb2993663]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.3 KDa. Observed: 28-40 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human NTNG1 (C-Fc) [orb2993664]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 70.2 KDa. Observed: 80-90 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Rhesus Macaque LILRB1 (C-6His) [orb2993665]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 48.5 KDa. Observed: 60-85 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human LRRC15 (C-6His) [orb2993666]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 58.8 KDa. Observed: 70-80 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Mouse IL-17RD (C-Fc) [orb2993667]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 58.7 KDa. Observed: 80-120 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Mouse IL-17RD (C-6His) [orb2993668]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 31.8 KDa. Observed: 40-65 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg